TP53 and amyotrophic lateral sclerosis: Likewise, TP53 TF activity was significantly increased in ALS iPSMNs in both library preparation groups (polyA datasets: NES + 6.54, p < 0.001; Ribo-Zero datasets: NES + 5.12, p < 0.001; Supplementary Fig. 9g, h).